UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
4 hedge funds and large institutions have $655K invested in Proshares UltraPro NASDAQ Biotechnology in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
$1.79M
Puts
$215K
Net Calls
+$1.58M
Net Calls Change
+$1.36M
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$53.7K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$49K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$355K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$298K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$73K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$47K |
| 5 |
Morgan Stanley
New York
|
-$3.22K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $446K | -$298K | -9,346 | -40% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $131K | +$53.7K | +1,686 | +69% |
|
|
3
Simplex Trading
Chicago,
Illinois
| $49K | +$49K | +1,552 | New |
|
|
4
Morgan Stanley
New York
| $29K | -$3.22K | -100 | -10% |
|
|
VF
5
Virtu Financial
New York
| – | -$355K | -12,843 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$73K | -2,651 | Closed |
|
|
CG
7
Cutler Group
San Francisco,
California
| – | -$47K | -1,733 | Closed |
|